Eur Rev Med Pharmacol Sci 2020; 24 (17): 8629-8629

DOI: 10.26355/eurrev_202009_22775

Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer

Y.-B. Shi, S.-L. Liu, X.-R. Mou, J. Liao, J.-P. Che, X.-Q. Fei, A.-R. Wang

Department of Cardiothoracic Surgery, Yantai Mountain Hospital, Yantai, China


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer, by Y.-B. Shi, S.-L. Liu, X.-R. Mou, J. Liao, J.-P. Che, X.-Q. Fei, A.-R. Wang, published in Eur Rev Med Pharmacol Sci 2020; 24 (3): 1243-1249–DOI: 10.26355/eurrev_202002_20177–PMID: 32096154” has been withdrawn.

 

The Publisher apologizes for any inconvenience this may cause.

Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer

Free PDF Download

To cite this article

Y.-B. Shi, S.-L. Liu, X.-R. Mou, J. Liao, J.-P. Che, X.-Q. Fei, A.-R. Wang
Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 17
Pages: 8629-8629
DOI: 10.26355/eurrev_202009_22775